Key points are not available for this paper at this time.
Design
Editorial
No takes yet. Share an insight, caveat, or question.
Caution is required when using single in vitro approaches to establish safety margins for drug-induced QRS prolongation, necessitating further preclinical and clinical validation.
Gintant et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: